1. Home
  2. ROL vs INSM Comparison

ROL vs INSM Comparison

Compare ROL & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ROL
  • INSM
  • Stock Information
  • Founded
  • ROL 1948
  • INSM 1988
  • Country
  • ROL United States
  • INSM United States
  • Employees
  • ROL N/A
  • INSM N/A
  • Industry
  • ROL Diversified Commercial Services
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • ROL Finance
  • INSM Health Care
  • Exchange
  • ROL Nasdaq
  • INSM Nasdaq
  • Market Cap
  • ROL 27.6B
  • INSM 26.0B
  • IPO Year
  • ROL N/A
  • INSM 2000
  • Fundamental
  • Price
  • ROL $56.16
  • INSM $144.78
  • Analyst Decision
  • ROL Buy
  • INSM Strong Buy
  • Analyst Count
  • ROL 8
  • INSM 19
  • Target Price
  • ROL $60.63
  • INSM $146.81
  • AVG Volume (30 Days)
  • ROL 1.5M
  • INSM 2.1M
  • Earning Date
  • ROL 10-22-2025
  • INSM 10-30-2025
  • Dividend Yield
  • ROL 1.18%
  • INSM N/A
  • EPS Growth
  • ROL 6.56
  • INSM N/A
  • EPS
  • ROL 1.01
  • INSM N/A
  • Revenue
  • ROL $3,570,470,000.00
  • INSM $398,105,000.00
  • Revenue This Year
  • ROL $12.43
  • INSM $31.95
  • Revenue Next Year
  • ROL $8.64
  • INSM $125.46
  • P/E Ratio
  • ROL $55.60
  • INSM N/A
  • Revenue Growth
  • ROL 10.38
  • INSM 21.15
  • 52 Week Low
  • ROL $45.34
  • INSM $60.40
  • 52 Week High
  • ROL $59.10
  • INSM $149.08
  • Technical
  • Relative Strength Index (RSI)
  • ROL 45.71
  • INSM 71.07
  • Support Level
  • ROL $55.00
  • INSM $138.73
  • Resistance Level
  • ROL $58.40
  • INSM $148.22
  • Average True Range (ATR)
  • ROL 0.98
  • INSM 3.85
  • MACD
  • ROL -0.11
  • INSM -0.92
  • Stochastic Oscillator
  • ROL 34.12
  • INSM 71.10

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: